drugset / Trial / NCT04691687

OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart Failure

NCT04691687

Phase 4 Completed 100 enrolled New York Presbyterian Brooklyn Methodist Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Single-center, prospective double-blinded randomized control trial to evaluate the the feasibility, efficacy and safety of outpatient IV diuretic therapy in treatment of heart failure.

Timeline

Start
2012-05-01
Primary completion
2017-12-22
Completion
2017-12-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 20 mg Intravenous
Subject Furosemide Other / unclassified 40 mg Intravenous
Subject Furosemide Other / unclassified 80 mg Intravenous

Indications